SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-08-079081
Filing Date
2008-04-10
Accepted
2008-04-10 17:03:48
Documents
2
Period of Report
2008-04-04
Items
Item 4.01: Changes in Registrant's Certifying Accountant
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K d8k.htm 8-K 15560
2 LETTER FROM J.H.COHN LLP TO THE SECURITIES AND EXCHANGE COMMISSION dex161.htm EX-16.1 2275
  Complete submission text file 0001193125-08-079081.txt   19443
Mailing Address 13950 BALLANTYNE CORPORATE PLACE UNIT 325 CHARLOTTE NC 28277
Business Address 13950 BALLANTYNE CORPORATE PLACE UNIT 325 CHARLOTTE NC 28277 704-341-1516
Chelsea Therapeutics International, Ltd. (Filer) CIK: 0001333763 (see all company filings)

IRS No.: 203174202 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-51462 | Film No.: 08750545
SIC: 2836 Biological Products, (No Diagnostic Substances)
Assistant Director 1